Nivolumab Effective in Liver Cancer, Child – Pugh B Status Nivolumab Effective in Liver Cancer, Child – Pugh B Status
New data from the CheckMate 040 trial suggest another indication is in the works for the checkpoint inhibitor nivolumab.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Source Type: news
More News: Cancer | Cancer & Oncology | Children | Gastroenterology | Health | Liver | Urology & Nephrology